Introduction
Mild Cognitive Impairment - Overview
Mild Cognitive Impairment - Therapeutics Development
Mild Cognitive Impairment - Therapeutics Assessment
Mild Cognitive Impairment - Companies Involved in Therapeutics Development
Mild Cognitive Impairment - Drug Profiles
Mild Cognitive Impairment - Dormant Projects
Mild Cognitive Impairment - Discontinued Products
Mild Cognitive Impairment - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Mild Cognitive Impairment, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Mild Cognitive Impairment - Pipeline by Actinogen Medical Ltd, 2021
Mild Cognitive Impairment - Pipeline by Acumen Pharmaceuticals Inc, 2021
Mild Cognitive Impairment - Pipeline by Addex Therapeutics Ltd, 2021
Mild Cognitive Impairment - Pipeline by AgeneBio Inc, 2021
Mild Cognitive Impairment - Pipeline by Aptinyx Inc, 2021
Mild Cognitive Impairment - Pipeline by AstraZeneca Plc, 2021
Mild Cognitive Impairment - Pipeline by CereSpir Inc, 2021
Mild Cognitive Impairment - Pipeline by CuraSen Therapeutics Inc, 2021
Mild Cognitive Impairment - Pipeline by Eisai Co Ltd, 2021
Mild Cognitive Impairment - Pipeline by Eli Lilly and Co, 2021
Mild Cognitive Impairment - Pipeline by FUJIFILM Toyama Chemical Co Ltd, 2021
Mild Cognitive Impairment - Pipeline by Grespo AB, 2021
Mild Cognitive Impairment - Pipeline by ImmunoChem Therapeutics LLC, 2021
Mild Cognitive Impairment - Pipeline by IntelGenx Corp, 2021
Mild Cognitive Impairment - Pipeline by INVENT Pharmaceuticals Inc, 2021
Mild Cognitive Impairment - Pipeline by Jupiter Orphan Therapeutics Inc, 2021
Mild Cognitive Impairment - Pipeline by KeifeRx LLC, 2021
Mild Cognitive Impairment - Pipeline by Merck & Co Inc, 2021
Mild Cognitive Impairment - Pipeline by NeurAegis Inc, 2021
Mild Cognitive Impairment - Pipeline by NeuroActiva Inc, 2021
Mild Cognitive Impairment - Pipeline by NKGen Biotech Inc, 2021
Mild Cognitive Impairment - Pipeline by NLS Pharma Group, 2021
Mild Cognitive Impairment - Pipeline by Novartis AG, 2021
Mild Cognitive Impairment - Pipeline by Novo Nordisk AS, 2021
Mild Cognitive Impairment - Pipeline by Octapharma AG, 2021
Mild Cognitive Impairment - Pipeline by Partner Therapeutics Inc, 2021
Mild Cognitive Impairment - Pipeline by Pfizer Inc, 2021
Mild Cognitive Impairment - Pipeline by Praetego Inc, 2021
Mild Cognitive Impairment - Pipeline by ProNeurogen Inc, 2021
Mild Cognitive Impairment - Pipeline by Protekt Therapeutics Ltd, 2021
Mild Cognitive Impairment - Pipeline by Sage Therapeutics Inc, 2021
Mild Cognitive Impairment - Pipeline by SBI Pharmaceuticals Co Ltd, 2021
Mild Cognitive Impairment - Pipeline by SciSparc Ltd, 2021
Mild Cognitive Impairment - Pipeline by Shackelford Pharma Inc, 2021
Mild Cognitive Impairment - Pipeline by TauRx Therapeutics Ltd, 2021
Mild Cognitive Impairment - Pipeline by UCB SA, 2021
Mild Cognitive Impairment - Dormant Projects, 2021
Mild Cognitive Impairment - Dormant Projects, 2021 (Contd..1)
Mild Cognitive Impairment - Dormant Projects, 2021 (Contd..2)
Mild Cognitive Impairment - Discontinued Products, 2021

List of Figures
Number of Products under Development for Mild Cognitive Impairment, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Actinogen Medical Ltd
• Acumen Pharmaceuticals Inc
• Addex Therapeutics Ltd
• AgeneBio Inc
• Aptinyx Inc
• AstraZeneca Plc
• CereSpir Inc
• CuraSen Therapeutics Inc
• Eisai Co Ltd
• Eli Lilly and Co
• FUJIFILM Toyama Chemical Co Ltd
• Grespo AB
• ImmunoChem Therapeutics LLC
• IntelGenx Corp
• INVENT Pharmaceuticals Inc
• Jupiter Orphan Therapeutics Inc
• KeifeRx LLC
• Merck & Co Inc
• NeurAegis Inc
• NeuroActiva Inc
• NKGen Biotech Inc
• NLS Pharma Group
• Novartis AG
• Novo Nordisk AS
• Octapharma AG
• Partner Therapeutics Inc
• Pfizer Inc
• Praetego Inc
• ProNeurogen Inc
• Protekt Therapeutics Ltd
• Sage Therapeutics Inc
• SBI Pharmaceuticals Co Ltd
• SciSparc Ltd
• Shackelford Pharma Inc
• TauRx Therapeutics Ltd
• UCB SA